Cardiac allograft vasculopathy history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Patients with cardiac allograft vasculopathy (CAV) do not present with typical angina symptoms due to cardiac denervation at the time of heart transplantation. CAV is responsible for approximately 40% of deaths in heart transplant recipients. Survival in these patients has improved significantly over the decades, owing primarily to improved diagnostic techniques, and optimal immunosuppression and risk factor modification. The 2013 adult heart transplant registry noted that 5-year survival in both pediatric and adult heart transplant recipients is 69%.  
Patients with cardiac allograft vasculopathy (CAV) seldom present with typical angina symptoms due to cardiac denervation at the time of heart transplantation.  


==History and Symptoms==
==History and Symptoms==
CAV may manifest as:
As mentioned above, patients with cardiac transplants do not typically present with [[angina|anginal]] symptoms. About 10-30% of patients regain some renervation to the heart. Hence, they typically present late with the following manifestations.
 
# [[Graft]] failure
# [[Graft]] failure
# [[Arrhythmia]]s
# [[Arrhythmia]]s

Revision as of 19:44, 20 December 2014

Cardiac allograft vasculopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Cardiac allograft vasculopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Coronary Angiography

Intravascular Ultrasound

Optical Coherence Tomography

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac allograft vasculopathy history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac allograft vasculopathy history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac allograft vasculopathy history and symptoms

CDC on Cardiac allograft vasculopathy history and symptoms

Cardiac allograft vasculopathy history and symptoms in the news

Blogs on Cardiac allograft vasculopathy history and symptoms

Directions to Hospitals Treating Cardiac allograft vasculopathy

Risk calculators and risk factors for Cardiac allograft vasculopathy history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

Patients with cardiac allograft vasculopathy (CAV) seldom present with typical angina symptoms due to cardiac denervation at the time of heart transplantation.

History and Symptoms

As mentioned above, patients with cardiac transplants do not typically present with anginal symptoms. About 10-30% of patients regain some renervation to the heart. Hence, they typically present late with the following manifestations.

  1. Graft failure
  2. Arrhythmias
  3. Silent myocardial infarction: Due to denervation at the time of surgery patients with CAV rarely present with typical angina symptoms, especially in the initial years of transplantation.[1] However, studies have demonstrated that re-innervation does occur late after heart transplantation.[2]
  4. Sudden death

References

  1. Di Cori A, Petronio AS, Gemignani C, Zucchelli G, Di Bello V, Mariani M (2005). "Symptomatic acute myocardial infarction in a cardiac transplant recipient successfully treated with primary coronary angioplasty: evidence of prognostic importance of chest pain after cardiac transplantation". J Heart Lung Transplant. 24 (8): 1146–9. doi:10.1016/j.healun.2004.07.003. PMID 16102462.
  2. Gallego-Page JC, Segovia J, Alonso-Pulpón L, Alonso-Rodríguez M, Salas C, Ortíz-Berrocal J (2004). "Re-innervation after heart transplantation: a multidisciplinary study". J Heart Lung Transplant. 23 (6): 674–82. PMID 15366426.

Template:WH Template:WS